Mackenzie Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-10,901
| Closed | -$1.27M | – | 1620 |
|
2023
Q3 | $1.27M | Sell |
10,901
-181
| -2% | -$21K | ﹤0.01% | 800 |
|
2023
Q2 | $1.14M | Sell |
11,082
-39,231
| -78% | -$4.04M | ﹤0.01% | 835 |
|
2023
Q1 | $5.49M | Buy |
+50,313
| New | +$5.49M | 0.01% | 530 |
|
2022
Q4 | – | Sell |
-79,514
| Closed | -$4.92M | – | 1625 |
|
2022
Q3 | $4.92M | Sell |
79,514
-2,688
| -3% | -$166K | 0.01% | 529 |
|
2022
Q2 | $6.56M | Buy |
82,202
+17,529
| +27% | +$1.4M | 0.01% | 502 |
|
2022
Q1 | $6.8M | Buy |
64,673
+33,416
| +107% | +$3.52M | 0.01% | 528 |
|
2021
Q4 | $3.37M | Sell |
31,257
-20,986
| -40% | -$2.26M | ﹤0.01% | 648 |
|
2021
Q3 | $5.72M | Buy |
52,243
+40,996
| +365% | +$4.49M | 0.01% | 548 |
|
2021
Q2 | $1.05M | Buy |
11,247
+209
| +2% | +$19.6K | ﹤0.01% | 856 |
|
2021
Q1 | $1.02M | Sell |
11,038
-16,554
| -60% | -$1.52M | ﹤0.01% | 810 |
|
2020
Q4 | $2.02M | Buy |
27,592
+9,635
| +54% | +$705K | ﹤0.01% | 601 |
|
2020
Q3 | $1.4M | Buy |
+17,957
| New | +$1.4M | ﹤0.01% | 615 |
|
2017
Q4 | – | Sell |
-51,000
| Closed | -$647K | – | 863 |
|
2017
Q3 | $647K | Buy |
51,000
+1,000
| +2% | +$12.7K | ﹤0.01% | 488 |
|
2017
Q2 | $594K | Hold |
50,000
| – | – | ﹤0.01% | 495 |
|
2017
Q1 | $739K | Buy |
+50,000
| New | +$739K | ﹤0.01% | 483 |
|
2015
Q3 | – | Sell |
-7,707
| Closed | -$268K | – | 849 |
|
2015
Q2 | $268K | Buy |
+7,707
| New | +$268K | ﹤0.01% | 754 |
|